Kalvista Price To Sales Ratio from 2010 to 2024
| KALV Stock | USD 10.06 0.03 0.30% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 58.07 | Current Value 46.33 | Quarterly Volatility 29.91479933 |
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 424 K, Interest Expense of 0.0 or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
Kalvista | Price To Sales Ratio |
Latest Kalvista Pharmaceuticals' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Kalvista Pharmaceuticals over the last few years. Price to Sales Ratio is figured by comparing Kalvista Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Kalvista Pharmaceuticals sales, a figure that is much harder to manipulate than other Kalvista Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Kalvista Pharmaceuticals' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 107.42 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Kalvista Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 42.02 | |
| Geometric Mean | 34.95 | |
| Coefficient Of Variation | 71.19 | |
| Mean Deviation | 19.27 | |
| Median | 37.57 | |
| Standard Deviation | 29.91 | |
| Sample Variance | 894.90 | |
| Range | 124 | |
| R-Value | 0.01 | |
| Mean Square Error | 963.59 | |
| R-Squared | 0.0001 | |
| Significance | 0.97 | |
| Slope | 0.08 | |
| Total Sum of Squares | 12,529 |
Kalvista Price To Sales Ratio History
About Kalvista Pharmaceuticals Financial Statements
Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 58.07 | 46.33 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.